NDC 60505-0096-01 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-0096
- Requested NDC
- 60505-0096-01
- Package NDCs from labels
- 60505-0096-0, 60505-0096-1, 60505-0096-8, 60505-0096-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-10-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - A-S Medication Solutions | A-S Medication Solutions | 2026-10-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin - Apotex Corp. | Apotex Inc. | Apotex Corp. | Apotex Inc. | 2026-09-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin - AvKARE | AvKARE | 2026-03-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin - AvPAK | AvPAK | 2026-03-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2025-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin - Legacy Pharmaceutical Packaging, LLC | Legacy Pharmaceutical Packaging, LLC | 2020-02-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-0096-0 | Doxazosin | 100 in 1 BOTTLE | TABLET | 100 | 15 | |
| 60505-0096-1 | Doxazosin | 1000 in 1 BOTTLE | TABLET | 1000 | 15 | |
| 60505-0096-8 | Doxazosin | 5000 in 1 BOTTLE | TABLET | 5000 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-0096 | DOXAZOSIN TABLET [APOTEX CORP.] | 14 | Current NDC, Legacy NDC, 3 package rows | 20240822_4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-0096-0 | EA - Each | 60505-0096 | 3376beac-ff37-4222-b9b3-6b5152d454ef | 1 | 2012-07-24 |
| 60505-0096-1 | EA - Each | 60505-0096 | a9f32422-499b-4773-83b8-1da702f75b76 | 1 | 2012-07-24 |
| 60505-0096-8 | EA - Each | 60505-0096 | bfa68409-7688-4ec4-a78b-de674507a91d | 1 | 2013-05-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 8c0c0345-833b-4a3d-9081-da66b208d750 | 2024-09-05 | Warnings, Adverse reactions | 197625 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | ef8b5534-5939-400a-ad5e-f9ceaefc4097 | 2024-09-05 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | ac4cd22b-2a03-47b6-9eed-550be278f17d | 2024-09-05 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Accord Healthcare Inc. | 2830533c-ccdf-4401-b19c-763eeb1bc0a7 | 2024-08-15 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 40e47e75-6a47-323b-e054-00144ff8d46c | 2024-08-14 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 505d3c4c-5506-72cc-e054-00144ff88e88 | 2024-07-09 | Warnings, Adverse reactions | ANDA075580 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 7991373e-8a62-47f9-b4fb-90573485af4e | 2024-07-04 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Rising Pharma Holdings, Inc. | 508b908e-8d80-422e-8ec0-2081185f4c95 | 2024-06-19 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 4034fb6d-f55d-4df0-b500-d6a413591f6e | 2024-06-12 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 9f67fa58-f623-4145-9e2c-98feee7ca45f | 2024-06-10 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 46b01b1d-c48a-4c36-bf3c-bba98066166c | 2024-06-10 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 64a243e6-7056-115d-e053-2a91aa0a510f | 2024-06-06 | Warnings, Adverse reactions | 197625 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 64a19cb1-79fc-8b0b-e053-2a91aa0aaa94 | 2024-06-06 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Proficient Rx LP | 1d8ff659-8129-4dca-9e8f-13b97240d1e1 | 2024-06-01 | Warnings, Adverse reactions | ANDA075580 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 187bc51b-7a3a-5910-e063-6294a90aa888 | 2024-05-15 | Warnings, Adverse reactions | 197628 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 6fbb9ca2-e8ca-45c7-a178-b4c8dd7a9a1f | 2024-04-29 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Mylan Pharmaceuticals Inc. | 2e524986-7903-416f-b2b8-d27295103e75 | 2024-03-11 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 0d9df8e9-f823-4ff8-a5fe-0309dd132b04 | 2024-02-06 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin Mesylate | DOXAZOSIN MESYLATE | Unichem Pharmaceuticals (USA), Inc. | 44bfe5d7-a56a-46f1-8ef3-ad386ab35f0f | 2024-01-23 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Cardura | DOXAZOSIN | Viatris Specialty LLC | 5e1f5e49-2da1-43ab-9795-228a8bcc5a82 | 2023-10-15 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.